209 related articles for article (PubMed ID: 19711341)
1. BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer.
Naderi A; Liu J; Bennett IC
Int J Cancer; 2010 Apr; 126(7):1596-610. PubMed ID: 19711341
[TBL] [Abstract][Full Text] [Related]
2. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
Naderi A; Liu J; Francis GD
Int J Cancer; 2012 Jan; 130(1):71-82. PubMed ID: 21384344
[TBL] [Abstract][Full Text] [Related]
3. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Naderi A; Liu J; Hughes-Davies L
Mol Cancer; 2010 May; 9():111. PubMed ID: 20482821
[TBL] [Abstract][Full Text] [Related]
4. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
[TBL] [Abstract][Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
[TBL] [Abstract][Full Text] [Related]
7. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
8. TOB suppresses breast cancer tumorigenesis.
O'Malley S; Su H; Zhang T; Ng C; Ge H; Tang CK
Int J Cancer; 2009 Oct; 125(8):1805-13. PubMed ID: 19569230
[TBL] [Abstract][Full Text] [Related]
9. BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.
Naderi A; Teschendorff AE; Beigel J; Cariati M; Ellis IO; Brenton JD; Caldas C
Cancer Res; 2007 Jul; 67(14):6725-36. PubMed ID: 17638883
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
[TBL] [Abstract][Full Text] [Related]
11. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
[TBL] [Abstract][Full Text] [Related]
12. Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.
Naderi A
Exp Cell Res; 2019 Mar; 376(2):221-226. PubMed ID: 30779920
[TBL] [Abstract][Full Text] [Related]
13. BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.
Nehra R; Riggins RB; Shajahan AN; Zwart A; Crawford AC; Clarke R
FASEB J; 2010 Jun; 24(6):2040-55. PubMed ID: 20154269
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms.
Tophkhane C; Yang S; Bales W; Archer L; Osunkoya A; Thor AD; Yang X
Int J Oncol; 2007 Oct; 31(4):867-74. PubMed ID: 17786319
[TBL] [Abstract][Full Text] [Related]
15. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
16. ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells.
Faouzi M; Kischel P; Hague F; Ahidouch A; Benzerdjeb N; Sevestre H; Penner R; Ouadid-Ahidouch H
Biochim Biophys Acta; 2013 Mar; 1833(3):752-60. PubMed ID: 23266555
[TBL] [Abstract][Full Text] [Related]
17. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
Deng X; Wu X; Weng H; Song F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1036-40. PubMed ID: 27412932
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells.
Shen YY; Yuan Y; Du YY; Pan YY
Mol Med Rep; 2015 Jul; 12(1):623-30. PubMed ID: 25738368
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
Chovolou Y; Wätjen W; Kampkötter A; Kahl R
Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]